TY - JOUR
T1 - Diverse monogenic subforms of human spermatogenic failure
AU - Nagirnaja, Liina
AU - Lopes, Alexandra M.
AU - Charng, Wu Lin
AU - Miller, Brian
AU - Stakaitis, Rytis
AU - Golubickaite, Ieva
AU - Stendahl, Alexandra
AU - Luan, Tianpengcheng
AU - Friedrich, Corinna
AU - Mahyari, Eisa
AU - Fadial, Eloise
AU - Kasak, Laura
AU - Vigh-Conrad, Katinka
AU - Oud, Manon S.
AU - Xavier, Miguel J.
AU - Cheers, Samuel R.
AU - James, Emma R.
AU - Guo, Jingtao
AU - Jenkins, Timothy G.
AU - Riera-Escamilla, Antoni
AU - Barros, Alberto
AU - Carvalho, Filipa
AU - Fernandes, Susana
AU - Gonçalves, João
AU - Gurnett, Christina A.
AU - Jørgensen, Niels
AU - Jezek, Davor
AU - Jungheim, Emily S.
AU - Kliesch, Sabine
AU - McLachlan, Robert I.
AU - Omurtag, Kenan R.
AU - Pilatz, Adrian
AU - Sandlow, Jay I.
AU - Smith, James
AU - Eisenberg, Michael L.
AU - Hotaling, James M.
AU - Jarvi, Keith A.
AU - Punab, Margus
AU - Rajpert-De Meyts, Ewa
AU - Carrell, Douglas T.
AU - Krausz, Csilla
AU - Laan, Maris
AU - O’Bryan, Moira K.
AU - Schlegel, Peter N.
AU - Tüttelmann, Frank
AU - Veltman, Joris A.
AU - Almstrup, Kristian
AU - Aston, Kenneth I.
AU - Conrad, Donald F.
N1 - Funding Information:
We thank all of the study participants and the numerous medical staff that enabled this study. We also acknowledge the contribution of the Lisbon clinical team - Carlos Calhaz-Jorge, Ana Aguiar, Joaquim Nunes, and Sandra Sousa (Unidade de Medicina da Reproducão, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisboa, Portugal), Maria Graça Pinto and Sónia Correia (Centro de Medicina Reprodutiva), for patients' clinical evaluation.The study has been funded by the following resources. National Institutes of Health of the United States of America grant R01HD078641 (D.F.C, K.I.A) National Institutes of Health of the United States of America grant P50HD096723 (D.F.C.) National Health and Medical Research Council of Australia grant APP1120356 (M.O., D.C., K.I.A., R.M., and J.A.V.) Spanish Ministry of Health Instituto Carlos III-FIS grant FIS/FEDER- PI20/01562 (C.K., A.R.-E.). Estonian Research Council grants IUT34-12 and PRG1021 (M.L., M.P.) ReproUnion and the Innovation Fund Denmark grant 14-2013-4 (K.A.) German Research Foundation Clinical Research Unit ‘Male Germ Cells’ grant DFG CRU326 (C.F., F.T.) The Netherlands Organization for Scientific Research VICI grant 918-15-667 (J.A.V.) Investigator Award in Science from the Wellcome Trust grant 209451 (J.A.V.). FCT/MCTES, through national funds attributed to Centre for Toxicogenomics and Human Health—ToxOmics, grant UID/BIM/00009/2016 (J.Go.) National Institute of Mental Health of the National Institutes of Health grant T32-MH014677 (W.-L.C).
Funding Information:
We thank all of the study participants and the numerous medical staff that enabled this study. We also acknowledge the contribution of the Lisbon clinical team - Carlos Calhaz-Jorge, Ana Aguiar, Joaquim Nunes, and Sandra Sousa (Unidade de Medicina da Reproducão, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisboa, Portugal), Maria Graça Pinto and Sónia Correia (Centro de Medicina Reprodutiva), for patients' clinical evaluation.The study has been funded by the following resources. National Institutes of Health of the United States of America grant R01HD078641 (D.F.C, K.I.A) National Institutes of Health of the United States of America grant P50HD096723 (D.F.C.) National Health and Medical Research Council of Australia grant APP1120356 (M.O., D.C., K.I.A., R.M., and J.A.V.) Spanish Ministry of Health Instituto Carlos III-FIS grant FIS/FEDER- PI20/01562 (C.K., A.R.-E.). Estonian Research Council grants IUT34-12 and PRG1021 (M.L., M.P.) ReproUnion and the Innovation Fund Denmark grant 14-2013-4 (K.A.) German Research Foundation Clinical Research Unit ‘Male Germ Cells’ grant DFG CRU326 (C.F., F.T.) The Netherlands Organization for Scientific Research VICI grant 918-15-667 (J.A.V.) Investigator Award in Science from the Wellcome Trust grant 209451 (J.A.V.). FCT/MCTES, through national funds attributed to Centre for Toxicogenomics and Human Health—ToxOmics, grant UID/BIM/00009/2016 (J.Go.) National Institute of Mental Health of the National Institutes of Health grant T32-MH014677 (W.-L.C).
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Non-obstructive azoospermia (NOA) is the most severe form of male infertility and typically incurable. Defining the genetic basis of NOA has proven challenging, and the most advanced classification of NOA subforms is not based on genetics, but simple description of testis histology. In this study, we exome-sequenced over 1000 clinically diagnosed NOA cases and identified a plausible recessive Mendelian cause in 20%. We find further support for 21 genes in a 2-stage burden test with 2072 cases and 11,587 fertile controls. The disrupted genes are primarily on the autosomes, enriched for undescribed human “knockouts”, and, for the most part, have yet to be linked to a Mendelian trait. Integration with single-cell RNA sequencing data shows that azoospermia genes can be grouped into molecular subforms with synchronized expression patterns, and analogs of these subforms exist in mice. This analysis framework identifies groups of genes with known roles in spermatogenesis but also reveals unrecognized subforms, such as a set of genes expressed across mitotic divisions of differentiating spermatogonia. Our findings highlight NOA as an understudied Mendelian disorder and provide a conceptual structure for organizing the complex genetics of male infertility, which may provide a rational basis for disease classification.
AB - Non-obstructive azoospermia (NOA) is the most severe form of male infertility and typically incurable. Defining the genetic basis of NOA has proven challenging, and the most advanced classification of NOA subforms is not based on genetics, but simple description of testis histology. In this study, we exome-sequenced over 1000 clinically diagnosed NOA cases and identified a plausible recessive Mendelian cause in 20%. We find further support for 21 genes in a 2-stage burden test with 2072 cases and 11,587 fertile controls. The disrupted genes are primarily on the autosomes, enriched for undescribed human “knockouts”, and, for the most part, have yet to be linked to a Mendelian trait. Integration with single-cell RNA sequencing data shows that azoospermia genes can be grouped into molecular subforms with synchronized expression patterns, and analogs of these subforms exist in mice. This analysis framework identifies groups of genes with known roles in spermatogenesis but also reveals unrecognized subforms, such as a set of genes expressed across mitotic divisions of differentiating spermatogonia. Our findings highlight NOA as an understudied Mendelian disorder and provide a conceptual structure for organizing the complex genetics of male infertility, which may provide a rational basis for disease classification.
UR - http://www.scopus.com/inward/record.url?scp=85144638273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144638273&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-35661-z
DO - 10.1038/s41467-022-35661-z
M3 - Article
C2 - 36572685
AN - SCOPUS:85144638273
VL - 13
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
IS - 1
M1 - 7953
ER -